Literature DB >> 17914432

A practical guide to the management of anophthalmia and microphthalmia.

N K Ragge1, I D Subak-Sharpe, J R O Collin.   

Abstract

Congenital anophthalmia and microphthalmia are rare developmental defects of the globe. They often arise in conjunction with other ocular defects such as coloboma and orbital cyst. They may also be part of more generalised syndromes, such as CHARGE syndrome. Anophthalmia, microphthalmia, and coloboma are likely to be caused by disturbances of the morphogenetic pathway that controls eye development, either as a result of primary genetic defect, or external gestational factors, including infection or drugs that can influence the smooth processes of morphogenesis. The ophthalmologist is often the primary carer for children with anophthalmia and microphthalmia, and as such can coordinate the multidisciplinary input needed to offer optimal care for these individuals, including vision and family support services. They are able to assess the vision and maximise the visual potential of the child and they can also ensure that the cosmetic and social impact of anophthalmia or microphthalmia is minimised by starting socket expansion or referring to a specialist oculoplastics and prosthetics unit. A coordinated approach with paediatrics is necessary to manage any associated conditions. Genetic diagnosis and investigations can greatly assist in providing a diagnosis and informed genetic counselling.

Entities:  

Mesh:

Year:  2007        PMID: 17914432     DOI: 10.1038/sj.eye.6702858

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  21 in total

Review 1.  Eye development genes and known syndromes.

Authors:  Anne M Slavotinek
Journal:  Mol Genet Metab       Date:  2011-09-29       Impact factor: 4.797

2.  [Therapy options for blind microphthalmos and clinical anophthalmos].

Authors:  M P Schittkowski
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

3.  What experimental embryology can teach us about the development of the extraocular muscles in anophthalmia: at the interface of basic and clinical sciences.

Authors:  Linda K McLoon
Journal:  Arch Ophthalmol       Date:  2011-08

4.  VAX1 mutation associated with microphthalmia, corpus callosum agenesis, and orofacial clefting: the first description of a VAX1 phenotype in humans.

Authors:  Anne M Slavotinek; Ryan Chao; Tomas Vacik; Mani Yahyavi; Hana Abouzeid; Tanya Bardakjian; Adele Schneider; Gary Shaw; Elliott H Sherr; Greg Lemke; Mohammed Youssef; Daniel F Schorderet
Journal:  Hum Mutat       Date:  2011-12-27       Impact factor: 4.878

5.  Survey of microphthalmia in Japan.

Authors:  Sachiko Nishina; Daijiro Kurosaka; Yasuhiro Nishida; Hiroyuki Kondo; Yuri Kobayashi; Noriyuki Azuma
Journal:  Jpn J Ophthalmol       Date:  2012-02-23       Impact factor: 2.447

6.  Gestational di-n-butyl phthalate exposure induced developmental and teratogenic anomalies in rats: a multigenerational assessment.

Authors:  P Mahaboob Basha; M J Radha
Journal:  Environ Sci Pollut Res Int       Date:  2016-12-12       Impact factor: 4.223

7.  Long-term outcomes after cosmetic customized prostheses and dermis fat graft in congenital anophthalmia: a retrospective multicentre study.

Authors:  Alessandra Claudia Modugno; Antonio Giordano Resti; Giacomilde Mazzone; Caterina Moretti; Maria Rosa Terreni; Giorgio Albanese; Gustavo Savino; Gabriela Grimaldi; Richard Collin
Journal:  Eye (Lond)       Date:  2018-07-24       Impact factor: 3.775

Review 8.  Genetics of anophthalmia and microphthalmia. Part 2: Syndromes associated with anophthalmia-microphthalmia.

Authors:  Anne Slavotinek
Journal:  Hum Genet       Date:  2018-10-30       Impact factor: 4.132

9.  Parent-of-origin effects in SOX2 anophthalmia syndrome.

Authors:  Robert J Osborne; Jennifer J Kurinczuk; Nicola K Ragge
Journal:  Mol Vis       Date:  2011-11-24       Impact factor: 2.367

10.  Anophthalmia including next-generation sequencing-based approaches.

Authors:  Philippa Harding; Brian P Brooks; David FitzPatrick; Mariya Moosajee
Journal:  Eur J Hum Genet       Date:  2019-07-29       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.